Previous studies have demonstrated that niclosamide does not impair PI3K/AKT signaling in human breast cancer MCF-7 cells [41], and it has no effect on this pathway in the human prostate cancer cell line DU145 nor in human glioma cell line A172 [54]. Here, AKT1 is linked to glioma.